UNIVERSIDAD DE M LAGA
Patent Applications and Registrations
Patent applications and USPTO patent grants for UNIVERSIDAD DE M LAGA.The latest application filed is for "nanosystem based on microrna for treating obsesity".
- UNIVERSIDAD DE M LAGA - Malaga N/A ES
- UNIVERSIDAD DE MÁLAGA - Málaga ES
| Patent | Date |
|---|---|
| Integrated mode converter and multiplexer Grant 11,360,261 - Gonzalez Andrade , et al. June 14, 2 | 2022-06-14 |
| Nanosystem Based On Microrna For Treating Obsesity App 20220170019 - LHAMYANI; Said ; et al. | 2022-06-02 |
| Method For Predicting Or Prognosticating The Response To The Treatment Of Multiple Sclerosis With Interferon Beta App 20220043006 - OLIVER MARTOS; Begona ; et al. | 2022-02-10 |
| Integrated polarization splitter Grant 11,131,809 - Villafranca Velasco , et al. September 28, 2 | 2021-09-28 |
| Hemorrhagic Cerebrospinal Fluid Neural Stem Cells App 20210207089 - FERN NDEZ MUNOZ; Beatriz ; et al. | 2021-07-08 |
| Tool coupling Grant 11,034,031 - Klein Hubert , et al. June 15, 2 | 2021-06-15 |
| Integrated Polarisation Splitter App 20210033789 - VILLAFRANCA VELASCO; Aitor ; et al. | 2021-02-04 |
| Integrated Mode Converter And Multiplexer App 20200225412A1 - | 2020-07-16 |
| Composition For Use In Detecting An Allergy To Clavulanic Acid App 20200055808 - MONTANEZ VEGA; Maria Isabel ; et al. | 2020-02-20 |
| Methods for treating or ameliorating multiple sclerosis Grant 10,393,758 - Fernandez Fernandez , et al. A | 2019-08-27 |
| Tool Coupling App 20190217483 - KLEIN HUBERT; Julius ; et al. | 2019-07-18 |
| Microrna signature as an indicator of the risk of early recurrence in patients with breast cancer Grant 10,059,998 - Lozano Castro , et al. August 28, 2 | 2018-08-28 |
| Arithmetic Units And Related Converters App 20170293471 - Hormigo Aguilar; Francisco Javier ; et al. | 2017-10-12 |
| Microrna Signature As An Indicator Of The Risk Of Early Recurrence In Patients With Breast Cancer App 20170002424 - Lozano Castro; Jose ; et al. | 2017-01-05 |
| Recombinant Protein And Uses Thereof In The Diagnosis Of Multiple Sclerosis App 20160011212 - Fernandez Fernandez; Oscar ; et al. | 2016-01-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 